首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   681篇
  免费   47篇
  国内免费   5篇
耳鼻咽喉   4篇
儿科学   20篇
妇产科学   5篇
基础医学   71篇
口腔科学   4篇
临床医学   44篇
内科学   139篇
皮肤病学   2篇
神经病学   106篇
特种医学   72篇
外科学   90篇
综合类   3篇
一般理论   2篇
预防医学   26篇
眼科学   2篇
药学   68篇
中国医学   7篇
肿瘤学   68篇
  2023年   5篇
  2022年   15篇
  2021年   15篇
  2020年   14篇
  2019年   19篇
  2018年   25篇
  2017年   18篇
  2016年   16篇
  2015年   27篇
  2014年   35篇
  2013年   26篇
  2012年   63篇
  2011年   58篇
  2010年   26篇
  2009年   29篇
  2008年   33篇
  2007年   36篇
  2006年   51篇
  2005年   40篇
  2004年   37篇
  2003年   31篇
  2002年   34篇
  2001年   3篇
  2000年   4篇
  1999年   4篇
  1998年   8篇
  1997年   4篇
  1996年   4篇
  1995年   5篇
  1994年   4篇
  1993年   4篇
  1992年   4篇
  1991年   4篇
  1990年   2篇
  1989年   1篇
  1988年   3篇
  1987年   3篇
  1986年   1篇
  1985年   3篇
  1984年   2篇
  1983年   1篇
  1982年   5篇
  1981年   1篇
  1979年   1篇
  1977年   3篇
  1976年   2篇
  1973年   1篇
  1972年   1篇
  1970年   1篇
  1904年   1篇
排序方式: 共有733条查询结果,搜索用时 21 毫秒
81.
82.
83.
ABSTRACT: Two years after resection of a left parietal glioma, a 46-year-old woman underwent F-FDG and F-DOPA brain PET/CT. FDG showed left parietal hypometabolism with crossed cerebellar diaschisis. No abnormally increased FDG activity was seen. F-DOPA PET/CT scan demonstrated focal left parietal uptake. Recurrent glioma was confirmed by surgical biopsy. F-DOPA may demonstrate abnormal amino acid metabolism in evaluation of recurrence of glioma.  相似文献   
84.
85.
86.
87.
88.

Background

Beyond progression after tyrosine kinase inhibitor in EGFR-positive non-small-cell lung cancer patients (BE-POSITIVE) was the first Italian multicenter observational study that reported the outcomes of first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in a “real-life” Caucasian EGFR-mutated non-small-cell lung cancer (NSCLC) population. The sharing of multi-institutional experiences represents a crucial strategy to enrich knowledge about uncommon EGFR mutations. Therefore, we performed a post hoc analysis of the BE-POSITIVE study.

Patients and Methods

Data of advanced NSCLC patients with uncommon EGFR mutations who received first-line first-generation EGFR-TKIs in 24 Italian Hospitals were collected. In this analysis we aimed to evaluate overall survival (OS), progression-free survival (PFS), and overall response rate (ORR) of EGFR-TKIs in NSCLC patients harboring uncommon EGFR mutations.

Results

Thirty-five patients harboring uncommon EGFR mutations (any mutation other than deletion 19 or substitution of leucine by arginine at codon 858) were included of the original 312 EGFR-mutated cases. Most of them were female (n = 20, 57.1%), former smokers (n = 23, 65.7%), with adenocarcinoma (n = 31, 88.6%). The most frequent EGFR mutations were G719X (n = 6, 17.2%) and L861Q (n = 5, 14.2%). The population presented an ORR of 25.7%, a median PFS of 5.19 months, and a median OS of 14.49 months. When stratified according to type of EGFR mutation, median OS ranged from 3.65 months for unspecified mutations to 21.29 for double EGFR mutations. Median PFS ranged from 1.77 months for unspecified mutations to 20.83 months for concomitant EGFR-anaplastic lymphoma kinase alteration. ORR varied from 0% in exon 18, 20 and double gene alteration to 66.6% in exon 19.

Conclusion

Our study supports the existence of a strong outcome heterogeneity within patients harboring uncommon EGFR mutations, which needs to be clarified to achieve a real personalized treatment strategy.  相似文献   
89.
90.
Increased titers of IgG anti-GM1 and anti-asialo GM1 (GA1) ganglioside antibodies are present in some patients with the Guillain-Barré syndrome, particularly with the motor axonal variant, and following infection with Campylobacter jejuni or parenteral administration of gangliosides. The subclass distribution of IgG anti-GM1 or GA1 antibodies from 19 patients with acute motor neuropathy and elevated antibody titers were measured by ELISA using mouse monoclonal antibodies specific for human IgG subclasses. The anti-GM1 or GA1 antibodies were predominantly of the IgG1 and IgG3 subclasses, which are capable of complement fixation, and are characteristic of a T cell-dependent antibody response.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号